Omar Ishrak is CEO & Chairman at Medtronic plc (MDT). They have made 10 open-market trades across 2 companies since 2013, most recently 2026-08-07.
CIK 0001523102
5 open-market purchases totalling $5.9M since 2019, against 5 sales. Across 5 scored buys the stock is down 1.8% at ninety days, and 0.4 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 60% | 40% |
| Avg Move | -1.6% | +0.7% | -1.8% |
| Alpha | -0.1% | +3.4% | -0.4% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INTC | BUY | 2023-01-30 | 2023-08-10 | $28.05 | $2K | -4.6% | +12.0% | +10.0% |
| INTC | BUY | 2022-02-22 | 2022-02-24 | $45.11 | $995K | +1.2% | +9.8% | -10.1% |
| INTC | BUY | 2021-10-28 | 2021-11-01 | $48.02 | $1.9M | +1.9% | -2.0% | -1.6% |
| MDT | SELL | 2020-10-09 | 2020-10-14 | $108.40 | $165K | +1.8% | +6.2% | +10.7% |
| MDT | BUY | 2020-02-20 | 2020-02-24 | $113.68 | $2.0M | -10.2% | -22.2% | -12.9% |
| MDT | BUY | 2019-01-09 | 2019-01-09 | $84.05 | $1.0M | +3.7% | +6.1% | +5.8% |
| MDT | SELL | 2017-09-15 | 2017-09-18 | $81.63 | $22.9M | -6.0% | -4.9% | +0.9% |
| MDT | SELL | 2017-03-15 | 2017-03-17 | $82.82 | $15.7M | -1.2% | -2.2% | +6.7% |
| MDT | SELL | 2016-09-15 | 2016-09-19 | $84.93 | $10.5M | -1.2% | -3.2% | -15.5% |
| MDT | SELL | 2016-03-17 | 2016-03-21 | $76.14 | $3.5M | +0.9% | +5.4% | +13.1% |
| MDT | SELL · 10b5-1 | 2015-09-15 | 2015-09-16 | $69.43 | $1.4M | -1.6% | -0.1% | -0.1% |
| MDT | SELL · 10b5-1 | 2015-09-15 | 2015-09-18 | $69.44 | $1.4M | -1.6% | -0.1% | -0.1% |
| MDT | SELL · 10b5-1 | 2015-03-13 | 2015-03-17 | $76.24 | $1.5M | -1.6% | -0.1% | -0.1% |
| MDT | SELL · 10b5-1 | 2014-03-14 | 2014-03-17 | $59.12 | $591K | -1.6% | -0.1% | -0.1% |
| MDT | SELL · 10b5-1 | 2013-09-13 | 2013-09-16 | $53.58 | $536K | -1.6% | -0.1% | -0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.